Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT01533948 · TERMINATED

Trial details

NCT number: NCT01533948
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Extraocular Extension Melanoma Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IIIA Intraocular Melanoma Stage IIIA Melanoma Stage IIIB Intraocular Melanoma Stage IIIB Melanoma Stage IIIC Intraocular Melanoma Stage IIIC Melanoma Stage IV Intraocular Melanoma Stage IV Melanoma

Start date: 2012-01-01
Primary completion: 2015-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.